Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamlet Gasoyan

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Diabetes, Obesity & Metabolism|March 12, 2026
Obesity Treatments and Weight Changes in Clinical Practice After Discontinuation of Semaglutide or TirzepatideHamlet Gasoyan, Rebecca Schulte, Christopher B Boyer, et al.
Ejhaem|May 18, 2026
Triplet or Quadruplet Regimen Utilization and Overall Survival in Patients Diagnosed With Multiple Myeloma Between 2017 and 2023Emily R Wesley, Faiz Anwer, Michael B Rothberg, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 29, 2024
Treatment Access among Younger Medicaid Beneficiaries with Multiple MyelomaMark A Fiala, Mengmeng Ji, Yi-Hsuan Shih, et al.
Annals of Surgery|June 11, 2024
Renoprotective Effects of Metabolic Surgery Versus GLP1 Receptor Agonists on Progression of Kidney Impairment in Patients with Established Kidney DiseaseAli Aminian, Hamlet Gasoyan, Alexander Zajichek, et al.
Nature Medicine|September 16, 2025
Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesityHamlet Gasoyan, Mohammad Hesam Alavi, Alexander Zajichek, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Diabetes, Obesity & Metabolism|March 12, 2026
Obesity Treatments and Weight Changes in Clinical Practice After Discontinuation of Semaglutide or TirzepatideHamlet Gasoyan, Rebecca Schulte, Christopher B Boyer, et al.
Ejhaem|May 18, 2026
Triplet or Quadruplet Regimen Utilization and Overall Survival in Patients Diagnosed With Multiple Myeloma Between 2017 and 2023Emily R Wesley, Faiz Anwer, Michael B Rothberg, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 29, 2024
Treatment Access among Younger Medicaid Beneficiaries with Multiple MyelomaMark A Fiala, Mengmeng Ji, Yi-Hsuan Shih, et al.
Annals of Surgery|June 11, 2024
Renoprotective Effects of Metabolic Surgery Versus GLP1 Receptor Agonists on Progression of Kidney Impairment in Patients with Established Kidney DiseaseAli Aminian, Hamlet Gasoyan, Alexander Zajichek, et al.
Nature Medicine|September 16, 2025
Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesityHamlet Gasoyan, Mohammad Hesam Alavi, Alexander Zajichek, et al.
Pageof 4